Advanced search
Publication Cover
Future Cardiology Volume 17, 2021 - Issue 4
Submit an article Journal homepage
1,214
Views
0
CrossRef citations to date
0
Altmetric
Editorial

Liver Hepatokines and Peroxisomes As Therapeutic Targets for Cardiovascular Diseases

Kerui Huang1 Department of Genetics Development & Cell Biology Iowa State University AmesIA50011USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-1866-8407View further author information
ORCID Icon &
Hua Bai1 Department of Genetics Development & Cell Biology Iowa State University AmesIA50011USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-5436-1245View further author information
ORCID Icon
Pages 535-538 | Received 30 Sep 2020, Accepted 05 Oct 2020, Published online: 22 Oct 2020

References

  • El Hadi H , DiVincenzo A, VettorR, RossatoM. Relationship between heart disease and liver disease: a two-way street. Cells, 9(3), 567 (2020).
  • Wiese S , HoveJD, BendtsenF, MollerS. Cirrhotic cardiomyopathy: pathogenesis and clinical relevance. Nat. Rev. Gastroenterol. Hepatol., 11(3), 177–186 (2014).
  • Vanwagner LB , LapinB, LevitskyJet al. High early cardiovascular mortality after liver transplantation. Liver Transpl., 20(11), 1306–1316 (2014).
  • Bezinover D , KadryZ, McculloughPet al. Release of cytokines and hemodynamic instability during the reperfusion of a liver graft. Liver Transpl., 17(3), 324–330 (2011).
  • Targher G , DayCP, BonoraE. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N. Engl. J. Med., 363(14), 1341–1350 (2010).
  • Targher G , ByrneCD, LonardoA, ZoppiniG, BarbuiC. Nonalcoholic fatty liver disease and risk of incident cardiovascular disease: a meta-analysis. J. Hepatol., 65(3), 589–600 (2016).
  • Motamed N , RabieeB, PoustchiHet al. Nonalcoholic fatty liver disease (NAFLD) and 10-year risk of cardiovascular diseases. Clin. Res. Hepatol. Gastroenterol., 41(1), 31–38 (2017).
  • Premoli A , PaschettaE, HvalrygM, SpandreM, BoS, DurazzoM. Characteristics of liver diseases in the elderly: a review. Minerva Gastroenterol. Dietol., 55(1), 71–78 (2009).
  • Huang K , MiaoT, ChangKet al. Impaired peroxisomal import in Drosophila oenocytes causes cardiac dysfunction by inducing upd3 as a peroxikine. Nature Communications, 11(1), 2943 (2020).
  • Dunn W , XuR, WingardDLet al. Suspected nonalcoholic fatty liver disease and mortality risk in a population-based cohort study. Am. J. Gastroenterol., 103(9), 2263–2271 (2008).
  • Akahoshi M , AmasakiY, SodaMet al. Correlation between fatty liver and coronary risk factors: a population study of elderly men and women in Nagasaki, Japan. Hypertens. Res., 24(4), 337–343 (2001).
  • Meex RCR , WattMJ. Hepatokines: linking nonalcoholic fatty liver disease and insulin resistance. Nat. Rev. Endocrinol., 13(9), 509–520 (2017).
  • Yoo HJ , ChoiKM. Hepatokines as a link between obesity and cardiovascular diseases. Diabetes Metab. J., 39(1), 10–15 (2015).
  • Fontes JA , RoseNR, CihakovaD. The varying faces of IL-6: from cardiac protection to cardiac failure. Cytokine, 74(1), 62–68 (2015).
  • Wieckowska A , PapouchadoBG, LiZ, LopezR, ZeinNN, FeldsteinAE. Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis. Am. J. Gastroenterol., 103(6), 1372–1379 (2008).
  • Pal D , DasguptaS, KunduRet al. Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance. Nat. Med., 18(8), 1279–1285 (2012).
  • Jung TW , YooHJ, ChoiKM. Implication of hepatokines in metabolic disorders and cardiovascular diseases. BBA Clin., 5, 108–113 (2016).
  • Haukeland JW , DahlTB, YndestadAet al. Fetuin A in nonalcoholic fatty liver disease: in vivo and in vitro studies. Eur. J. Endocrinol., 166(3), 503–510 (2012).
  • Waterham HR , FerdinandusseS, WandersRJ. Human disorders of peroxisome metabolism and biogenesis. Biochim. Biophys. Acta, 1863(5), 922–933 (2016).
  • Baes M , GressensP, BaumgartEet al. A mouse model for Zellweger syndrome. Nat. Genet., 17(1), 49–57 (1997).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.